PLx Pharma Inc. (PLXP) Stock Overview
Explore PLx Pharma Inc.’s financial performance, market position, analyst ratings, and future outlook.
PLx Pharma Inc. (PLXP)
Key Financials
Key Financials
Market Cap
2.5M
P/E Ratio
-0.04
EPS (TTM)
$-0.39
ROE
-1.66%
PLXP Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of PLx Pharma Inc. (PLXP) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of $0.00.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.04 and a market capitalization of 2.5M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.